argenx

👥 501-1000💰 $1,097,641,460 Post-IPO Equity over 1 year agoBiotechnologyTherapeuticsClinical Trials
Website LinkedIn Email Twitter

argenx is a global immunology company dedicated to enhancing the quality of life for individuals afflicted with severe autoimmune diseases and cancer.

Related companies: